Showing results (31-40 of 93) with videos related to

Sort By:
Pageof 10
Proceedings of the National Academy of Sciences of the United States of America|September 15, 2025
Peritumoral macrophages recruit eosinophils to promote antitumor immune responses in breast cancerJoseph Saglimbeni, Eduardo Esteva, Josue Canales, et al.
Cancer Immunology, Immunotherapy : CII|April 6, 2011
Expression of cancer testis antigens in human BRCA-associated breast cancers: potential targets for immunoprevention?Sylvia Adams, Luba Greeder, Elsa Reich, et al.
Annals of Surgical Oncology|July 11, 2018
Post-mastectomy Radiation Therapy in Breast Cancer Patients with Nodal MicrometastasesS Peter Wu, Moses Tam, Fauzia Shaikh, et al.
Scientific Reports|June 14, 2019
Transcriptomic profiles conducive to immune-mediated tumor rejection in human breast cancer skin metastases treated with ImiquimodMariya Rozenblit, Wouter Hendrickx, Adriana Heguy, et al.
Annals of Surgical Oncology|June 27, 2019
Tumor-Infiltrating Lymphocytes in a Contemporary Cohort of Women with Ductal Carcinoma In Situ (DCIS)Farbod Darvishian, Ugur Ozerdem, Sylvia Adams, et al.
Cancer Research|November 18, 2008
Type 2 Bias of T cells expanded from the blood of melanoma patients switched to type 1 by IL-12p70 mRNA-transfected dendritic cellsKira Minkis, Daniel G Kavanagh, Galit Alter, et al.
Cancer Cell|September 3, 2021
Activating a collaborative innate-adaptive immune response to control metastasisLijuan Sun, Tim Kees, Ana Santos Almeida, et al.
The Lancet. Oncology|June 23, 2015
Local radiotherapy and granulocyte-macrophage colony-stimulating factor to generate abscopal responses in patients with metastatic solid tumours: a proof-of-principle trialEncouse B Golden, Arpit Chhabra, Abraham Chachoua, et al.
Breast Cancer Research and Treatment|January 6, 2024
Effectiveness and toxicity of five-fraction prone accelerated partial breast irradiationCamille Hardy-Abeloos, Julie Xiao, Cheongeun Oh, et al.
JAMA Oncology|October 23, 2018
Atezolizumab Plus nab-Paclitaxel in the Treatment of Metastatic Triple-Negative Breast Cancer With 2-Year Survival Follow-up: A Phase 1b Clinical TrialSylvia Adams, Jennifer R Diamond, Erika Hamilton, et al.
Pageof 10